A frequent co-author of Ulrich Lichtenthaler — the management professor who has retracted at least eight papers — has now withdrawn one of his own from Research Policy.
One of the two corrections recommended by a McGill committee for work by Maya Saleh and colleagues has appeared, in the Proceedings of the National Academy of Sciences (PNAS).
two figures in [a] Nature paper had been “intentionally contrived and falsified.” One of those figures was duplicated in a PNAS paper, which also contained an image that had incorrectly labeled some proteins.
A German professor who claims to have developed “a self-consistent field theory which is used to derive at all known interactions of the potential vortex” will have at least two papers retracted, thanks to the scrutiny of a concerned economist.
Automattic, which runs WordPress, notified us tonight of the move, which comes two weeks after the original notice. The claim against Retraction Watch was ridiculous, of course; a site in India plagiarized our posts, then claimed we had violated their copyright. That site, perhaps not surprisingly, has been taken down.
The journal Proteomics has retracted a paper for a plagiarized figure — but how the authors came to possess the image in the first place remains a mystery.
If you wanted to minimize the real-life effects of misconduct, you might note that some of the retractions we cover are in tiny obscure journals hardly anyone reads. But a new meta-analysis and editorial in JAMA today suggests — as a study by Grant Steen did a few years ago — that the risk of patient harm due to scientific misconduct is not just theoretical.
As the editorialists note, hydroxyethyl starches (HES) are “synthetic fluid products used commonly in clinical practice worldwide:”
Synthetic colloids received market approval in the 1960s without evaluation of their efficacy and safety in large phase 3 clinical trials. Subsequent studies reported mixed evidence on their benefits and harms.
Would you hire someone found to have faked data on federal grant applications as a “grant services consultant?”
You may have been without knowing it, if you had gone to Washington, D.C.-based Strategic Health Care for help with your grants. There, you would have found Michael Miller — page removed today, more on that in a moment — whose bio described him as an “internationally known neuroscientist.”
He has more than 30 years of experience in obtaining federal support for his research and that of collaborators. This includes individual grants (R01′s and R03′s) and fellowships for himself and pre- and post-doctoral trainees from the National Institutes of Health (NIH), merit reviews and research career awards from the Department of Veterans Affairs, and support from private foundations. In addition, Dr. Miller successfully orchestrated and competed for a $9 million NIH center (P50) grant that coordinated research at five different institutions.